RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @ArulImmanuel: Interesting and important statistics! https://t.co/a68QYVN0Y9
RT @ArulImmanuel: Interesting and important statistics! https://t.co/a68QYVN0Y9
RT @schoolofsurgery: #Oesophagectomy is optimal within 65 days after neoadjuvant #chemoradiotherapy in #EsophagealCancer https://t.co/n1KyC…
Interesting and important statistics!
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
#Oesophagectomy is optimal within 65 days after neoadjuvant #chemoradiotherapy in #EsophagealCancer
RT SocSurgOnc RT AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in #EsophagealCancer Patients. https://t.co/ob7ARQhwJA McMastersKelly SocSurgOnc https://t.
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
RT @AnnSurgOncol: MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Over…
MARCH ISSUE: Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in #EsophagealCancer Patients. https://t.co/P5HnjGblrp @McMastersKelly @SocSurgOnc https://t.co/R8h4ZwC3Io